Identifying individuals with a reduced GFR using ambulatory laboratory database surveillance

Journal of the American Society of Nephrology

Volumn 16, Issue 5, 2005, Pages 1433-1439

  Garg, Amit X ^a   Mamdani, Muhammad ^b,d   Juurlink, David N ^c,d   Van Walraven, Carl ^d,e,f  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

AMBULATORY MONITORING; ARTICLE; CANADA; CREATININE BLOOD LEVEL; DATA BASE; GLOMERULUS FILTRATION RATE; HEALTH SURVEY; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION TEST; LABORATORY TEST; OUTPATIENT CARE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TECHNIQUE; ALGORITHM; BLOOD; CHRONIC KIDNEY FAILURE; FACTUAL DATABASE; MASS SCREENING; METHODOLOGY; OUTPATIENT; RISK FACTOR; STATISTICS;

ALGORITHMS; CREATININE; DATABASES, FACTUAL; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MASS SCREENING; ONTARIO; OUTPATIENTS; RISK FACTORS;

EID: 23944451229     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004080697     Document Type: Article

References (39)

1. Bennett PH, Haffner S, Kasiske BL, Keane WF, Mogensen CE, Parving HH, Steffes MW, Striker GE: Screening and management of microalbuminuria in patients with diabetes mellitus: Recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am J Kidney Dis 25: 107-112, 1995
2. Keane WF, Eknoyan G: Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): A position paper of the National Kidney Foundation. Am J Kidney Dis 33: 1004-1010, 1999
3. Mendelssohn DC, Barrett BJ, Brownscombe LM, Ethier J, Greenberg DE, Kanani SD, Levin A, Toffelmire EB: Elevated levels of serum creatinine: Recommendations for management and referral. CMAJ 161: 413-417, 1999
4. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289: 2560-2572, 2003
5. Zarnke KB, McAlister FA, Campbell NR, Levine M, Schiffrin EL, Grover S, McKay DW, Myers MG, Wilson TW, Rabkin SW, Feldman RD, Burgess E, Bolli P, Honos G, Lebel M, Mann K, Abbott C, Tobe S, Petrella R, Touyz RM; Canadian Hypertension Recommendations Working Group: The 2001 Canadian recommendations for the management of hypertension: Part one-Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification. Can J Cardiol 18: 604-624, 2002
6. Kshirsagar AV, Joy MS, Hogan SL, Falk RJ, Colindres RE: Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: A systematic overview of randomized placebo-controlled trials. Am J Kidney Dis 35: 695-707, 2000
7. Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, Maschio G, Brenner BM, Kamper A, Zucchelli P, Becker G, Himmelmann A, Bannister K, Landais P, Shahinfar S, de Jong PE, de Zeeuw D, Lau J, Levey AS: Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med 135: 73-87, 2001
8. Maki DD, Ma JZ, Louis TA, Kasiske BL: Long-term effects of antihypertensive agents on proteinuria and renal function. Arch Intern Med 155: 1073-1080, 1995
9. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL: Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 123: 754-762, 1995
10. Cleveland DR, Jindal KK, Hirsch DJ, Kiberd BA: Quality of prereferral care in patients with chronic renal insufficiency. Am J Kidney Dis 40: 30-36, 2002
11. Hsu CY, Bates DW, Kuperman GJ, Curhan GC: Blood pressure and angiotensin converting enzyme inhibitor use in hypertensive patients with chronic renal insufficiency. Am J Hypertens 14: 1219-1225, 2001
12. Nissenson AR, Collins AJ, Hurley J, Petersen H, Pereira BJ, Steinberg EP: Opportunities for improving the care of patients with chronic renal insufficiency: Current practice patterns. J Am Soc Nephrol 12: 1713-1720, 2001
13. Hsu CY, Vittinghoff E, Lin F, Shlipak MG: The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med 141: 95-101, 2004
14. Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM: Albuminuria and renal insufficiency prevalence guides population screening: Results from the NHANES III. Kidney Int 61: 2165-2175, 2002
15. Barrett BJ: Applying multiple interventions in chronic kidney disease. Semin Dial 16: 157-164, 2003
16. Ofman JJ, Badamgarav E, Henning JM, Knight K, Gano AD Jr, Levan RK, Gur-Arie S, Richards MS, Hasselblad V, Weingarten SR: Does disease management improve clinical and economic outcomes in patients with chronic diseases? A systematic review. Am J Med 117: 182-192, 2004
17. Warsi A, Wang PS, LaValley MP, Avorn J, Solomon DH: Self-management education programs in chronic disease: A systematic review and methodological critique of the literature. Arch Intern Med 164: 1641-1649, 2004
18. Grimshaw JM, Shirran L, Thomas R, Mowatt G, Fraser C, Bero L, Grilli R, Harvey E, Oxman A, O'Brien MA: Changing provider behavior: An overview of systematic reviews of interventions. Med Care 239[Suppl 2]: II2-II45, 2001
19. Stone EG, Morton SC, Hulscher ME, Maglione MA, Roth EA, Grimshaw JM, Mittman BS, Rubenstein LV, Rubenstein LZ, Shekelle PG: Interventions that increase use of adult immunization and cancer screening services: A meta-analysis. Ann Intern Med 136: 641-651, 2002
20. Hunt DL, Haynes RB, Hanna SE, Smith K: Effects of computer-based clinical decision support systems on physician performance and patient outcomes: A systematic review. JAMA 280: 1339-1346, 1998
21. Akbari A, Swedko PJ, Clark HD, Hogg W, Lemelin J, Magner P, Moore L, Ooi D: Detection of chronic kidney disease with laboratory reporting of estimated glomerular filtration rate and an educational program. Arch Intern Med 164: 1788-1792, 2004
22. Craig JC, Barratt A, Cumming R, Irwig L, Salkeld G: Feasibility study of the early detection and treatment of renal disease by mass screening. Intern Med J 32: 6-14, 2002
23. van Walraven C, Raymond M: Population-based study of repeat laboratory testing. Clin Chem 49: 1997-2005, 2003
24. Nissenson AR, Pereira BJ, Collins AJ, Steinberg EP: Prevalence and characteristics of individuals with chronic kidney disease in a large health maintenance organization. Am J Kidney Dis 37: 1177-1183, 2001
25. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
26. Chan BT, Ovens HJ: Frequent users of emergency departments. Do they also use family physicians' services? Can Fam Physician 48: 1654-1660, 2002
27. Oliver M, Lok C, Shi J, Rothwell DM. Diabetes in Ontario: An ICES practice atlas. In: Diabetes in Ontario: An ICES Practice Atlas, edited by Hux JE, Booth GI, Slaughter PM, Laupacis A, Toronto, Canada, Institute for Clinical Evaluative Sciences, 2003, pp 8.165-8.180
28. Hux JE, Ivis F, Flintoft V, Bica A: Diabetes in Ontario: Determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 25: 512-516, 2002
29. Manjunath G, Sarnak MJ, Levey AS: Prediction equations to estimate glomerular filtration rate: An update. Curr Opin Nephrol Hypertens 10: 785-792, 2001
30. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164: 659-663, 2004
31. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
32. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 39[Suppl 2]: S1-246, 2002
33. Couchoud C, Pozet N, Labeeuw M, Pouteil-Noble C: Screening early renal failure: Cut-off values for serum creatinine as an indicator of renal impairment. Kidney Int 55: 1878-1884, 1999
34. Clase CM, Garg AX, Kiberd BA: Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol 13: 1338-1349, 2002
35. Weiner JP, Parente ST, Garnick DW, Fowles J, Lawthers AG, Palmer RH: Variation in office-based quality. A claims-based profile of care provided to Medicare patients with diabetes. JAMA 273: 1503-1508, 1995
36. Lowrance W: Learning from experience: Privacy and the secondary use of data in health research. J Health Serv Res Policy 8[Suppl 1]: S1-S7, 2003
37. Sandy LG: The future of physician profiling. J Ambul Care Manage 22: 11-16, 1999
38. Coresh J, Astor BC, McQuillan G, Kusek J, Greene T, Van Lente F, Levey AS: Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 39: 920-929, 2002
39. Coresh J, Eknoyan G, Levey AS: Estimating the prevalence of low glomerular filtration rate requires attention to the creatinine assay calibration. J Am Soc Nephrol 13: 2811-2812, 2002